The level of LINC00346 was found to be negatively associated with overall survival in nasopharyngeal carcinoma (Cui et al., 2020), lung adenocarcinoma (Wang Z. et al., 2021), glioma (Chen X. et al., 2020; Geng et al., 2020), breast cancer (Liu et al., 2016), and pancreatic cancer (Zhang et al., 2018; Peng et al., 2019). This evidence concerns the gene PRECSIT and breast carcinoma.